214 related articles for article (PubMed ID: 23516507)
21. Strategies for Using Muramyl Peptides - Modulators of Innate Immunity of Bacterial Origin - in Medicine.
Guryanova SV; Khaitov RM
Front Immunol; 2021; 12():607178. PubMed ID: 33959120
[TBL] [Abstract][Full Text] [Related]
22.
Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
[TBL] [Abstract][Full Text] [Related]
23. Conserved host-pathogen PPIs. Globally conserved inter-species bacterial PPIs based conserved host-pathogen interactome derived novel target in C. pseudotuberculosis, C. diphtheriae, M. tuberculosis, C. ulcerans, Y. pestis, and E. coli targeted by Piper betel compounds.
Barh D; Gupta K; Jain N; Khatri G; León-Sicairos N; Canizalez-Roman A; Tiwari S; Verma A; Rahangdale S; Shah Hassan S; dos Santos AR; Ali A; Guimarães LC; Thiago Jucá Ramos R; Devarapalli P; Barve N; Bakhtiar M; Kumavath R; Ghosh P; Miyoshi A; Silva A; Kumar A; Misra AN; Blum K; Baumbach J; Azevedo V
Integr Biol (Camb); 2013 Mar; 5(3):495-509. PubMed ID: 23288366
[TBL] [Abstract][Full Text] [Related]
24. Incorporating the type and direction information in predicting novel regulatory interactions between HIV-1 and human proteins using a biclustering approach.
Mukhopadhyay A; Ray S; Maulik U
BMC Bioinformatics; 2014 Jan; 15():26. PubMed ID: 24460683
[TBL] [Abstract][Full Text] [Related]
25. Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?
Steinstraesser L; Kraneburg UM; Hirsch T; Kesting M; Steinau HU; Jacobsen F; Al-Benna S
Int J Mol Sci; 2009 Sep; 10(9):3951-3970. PubMed ID: 19865528
[TBL] [Abstract][Full Text] [Related]
26.
Wang X; Rockey DD; Dolan BP
Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32423914
[No Abstract] [Full Text] [Related]
27. Identification of putative TAL effector targets of the citrus canker pathogens shows functional convergence underlying disease development and defense response.
Pereira AL; Carazzolle MF; Abe VY; de Oliveira ML; Domingues MN; Silva JC; Cernadas RA; Benedetti CE
BMC Genomics; 2014 Feb; 15():157. PubMed ID: 24564253
[TBL] [Abstract][Full Text] [Related]
28. A
Rahbari KM; Chang JC; Federle MJ
mBio; 2021 May; 12(3):. PubMed ID: 33947757
[TBL] [Abstract][Full Text] [Related]
29. The landscape of human proteins interacting with viruses and other pathogens.
Dyer MD; Murali TM; Sobral BW
PLoS Pathog; 2008 Feb; 4(2):e32. PubMed ID: 18282095
[TBL] [Abstract][Full Text] [Related]
30. Subolesin expression in response to pathogen infection in ticks.
Zivkovic Z; Torina A; Mitra R; Alongi A; Scimeca S; Kocan KM; Galindo RC; Almazán C; Blouin EF; Villar M; Nijhof AM; Mani R; La Barbera G; Caracappa S; Jongejan F; de la Fuente J
BMC Immunol; 2010 Feb; 11():7. PubMed ID: 20170494
[TBL] [Abstract][Full Text] [Related]
31. Prioritizing drug targets in Clostridium botulinum with a computational systems biology approach.
Muhammad SA; Ahmed S; Ali A; Huang H; Wu X; Yang XF; Naz A; Chen J
Genomics; 2014 Jul; 104(1):24-35. PubMed ID: 24837790
[TBL] [Abstract][Full Text] [Related]
32. Discovering biclusters in gene expression data based on high-dimensional linear geometries.
Gan X; Liew AW; Yan H
BMC Bioinformatics; 2008 Apr; 9():209. PubMed ID: 18433477
[TBL] [Abstract][Full Text] [Related]
33. Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting.
Zilbermintz L; Leonardi W; Jeong SY; Sjodt M; McComb R; Ho CL; Retterer C; Gharaibeh D; Zamani R; Soloveva V; Bavari S; Levitin A; West J; Bradley KA; Clubb RT; Cohen SN; Gupta V; Martchenko M
Sci Rep; 2015 Aug; 5():13476. PubMed ID: 26310922
[TBL] [Abstract][Full Text] [Related]
34. Bacterial stress response: understanding the molecular mechanics to identify possible therapeutic targets.
Kumar A; Rahal A; Sohal JS; Gupta VK
Expert Rev Anti Infect Ther; 2021 Feb; 19(2):121-127. PubMed ID: 32811215
[TBL] [Abstract][Full Text] [Related]
35. Genetic Screen in Chlamydia muridarum Reveals Role for an Interferon-Induced Host Cell Death Program in Antimicrobial Inclusion Rupture.
Giebel AM; Hu S; Rajaram K; Finethy R; Toh E; Brothwell JA; Morrison SG; Suchland RJ; Stein BD; Coers J; Morrison RP; Nelson DE
mBio; 2019 Apr; 10(2):. PubMed ID: 30967464
[TBL] [Abstract][Full Text] [Related]
36. Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream.
Van Tyne D; Manson AL; Huycke MM; Karanicolas J; Earl AM; Gilmore MS
Sci Transl Med; 2019 Apr; 11(487):. PubMed ID: 30971455
[TBL] [Abstract][Full Text] [Related]
37. Aligning antimicrobial drug discovery with complex and redundant host-pathogen interactions.
Lebeis SL; Kalman D
Cell Host Microbe; 2009 Feb; 5(2):114-22. PubMed ID: 19218083
[TBL] [Abstract][Full Text] [Related]
38. The Canonical Long-Chain Fatty Acid Sensing Machinery Processes Arachidonic Acid To Inhibit Virulence in Enterohemorrhagic Escherichia coli.
Ellermann M; Jimenez AG; Pifer R; Ruiz N; Sperandio V
mBio; 2021 Jan; 12(1):. PubMed ID: 33468701
[TBL] [Abstract][Full Text] [Related]
39. Co-transcriptomic Analysis by RNA Sequencing to Simultaneously Measure Regulated Gene Expression in Host and Bacterial Pathogen.
Ravasi T; Mavromatis CH; Bokil NJ; Schembri MA; Sweet MJ
Methods Mol Biol; 2016; 1390():145-58. PubMed ID: 26803628
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms employed by enteric bacterial pathogens to antagonise host innate immunity.
Gan J; Giogha C; Hartland EL
Curr Opin Microbiol; 2021 Feb; 59():58-64. PubMed ID: 32862049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
